Entheon Biomedical (OTC:ENTBF) Stock, Quote.Headers.trade-ideas

Entheon Biomedical Corp is a biotechnology research and development company committed to treat addiction and substance use disorders.

Cannabis

News

Penny Stocks

Psychedelics

Guidance

Small Cap

Global

Markets

ATAI

AWKNF

CYBN

ENTBF

ENVB

KONEF

MNMD

MYDECINE INNOV GRP by MYDECINE INNOVATIONS GROUP INC.

MYCOF

NMDBF

NUMIF

FTHWF

The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business landscape.

World Class Leaders In Psychedelics Form Benzinga&#39;s Psychedelic Advisory Council—Get To Know Them

FLHLF

JAGX

LOBEF

MSSTF

NVMDF

OPTHF

SILFF

TRYPF

TSLA

TWTR

CSE:ENBI

CSE:SILO

Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider.

Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill

Biotech

Eurozone

Contracts

Asset Sales

General

CYBE

Cybin Inc. (NEO:CYBN) (NYSE American: CYBE) announced that, through its wholly-owned subsidiary Cybin IRL Limited, It has entered into an agreement to acquire a Phase 1 N,N-dimethyltryptamine (“DMT”) study from Entheon Biomedical Corp.

Largest Phase-1 DMT Study In The Netherlands, A Collaboration Between Entheon &amp; Cybin

ENTHEON BIOMEDICAL CORP by ENTHEON BIOMEDICAL CORP.

Entheon Biomedical Corp

Entheon Biomedical

Comments

Entheon Biomedical

Entheon Biomedical (OTC:ENTBF) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell